Edition:
United Kingdom

BioXcel Therapeutics Inc (BTAI.OQ)

BTAI.OQ on NASDAQ Stock Exchange Capital Market

9.15USD
16 Aug 2019
Change (% chg)

$0.48 (+5.54%)
Prev Close
$8.67
Open
$8.74
Day's High
$9.15
Day's Low
$8.55
Volume
3,885
Avg. Vol
13,329
52-wk High
$11.94
52-wk Low
$2.41

About

BioXcel Therapeutics, Inc. is a clinical stage biopharmaceutical company that is focused on the development of drugs for psychiatric disorders and rare cancers. The Company uses novel artificial intelligence (AI) for drug re-innovation processes of approved product candidates to identify new therapeutic indices. Its principal... (more)

Overall

No Ratios Available.

Financials

  BTAI.OQ Industry Sector
P/E (TTM): -- 69.38 32.67
EPS (TTM): -- -- --
ROI: -- 8.94 14.48
ROE: -- 10.07 15.78
Reuters.com is improving our Quote page. Click here to take a look and let us know what you think.

Earnings vs. Estimates